Manchandan Sandhu Leads Life Sciences Team

With extensive experience in the life sciences sector, including a tenure of over seven years at RWS where she held several sales leadership and strategic growth roles, Sandhu will be responsible for powering Acolad’s global strategy for the segment. Additionally, she will drive the expansion of our Clinical Center of Excellence, leveraging her deep expertise in Linguistic Validation and Clinical Translation.

“Welcoming Chan into our team is an amazing opportunity to further position Acolad as a true challenger in Life Sciences.” said Arnaud Daix, Executive Vice President for North America at Acolad. “She will be a key asset to our growth strategy, and her leadership and interpersonal skills will be an inspiration to our teams around the world.”

“I am excited to be joining such a visionary organization to lead its talented Life Sciences team, at such a pivotal moment for the industry” added Sandhu, on her new assignment. “As we tackle shifting global situations and complex health challenges, content and language service providers play a crucial role in fostering communication and innovation within the life sciences industry. It is our responsibility to add value through Gen-AI and a forward-thinking technology stack, which I am thrilled to see in play at Acolad. It is a privilege to be part of all this and to embrace Acolad’s vision of a world where every organization communicates effortlessly across languages and cultures. ”

Built on a legacy of over 30 years, and leveraging a global footprint spanning 23 countries, our expertise in the content and language services space is unparalleled, as is our commitment to servicing the Life Sciences industry with unwavering quality through our dedicated unit – Acolad Life Sciences.

Specializing in certified language solutions for pharma, medical devices, medtech and clinical research organizations and supported by a team of expert medical translators and a wide-array of technology-driven language solutions, Acolad Life Sciences partners with clients through every stage of product development - from clinical trials to post-market surveillance.

The recent launch of our Clinical Center of Excellence underscores our commitment to delivering culturally accurate translations of patient-facing and clinical trial documents. This initiative ensures precision, cultural sensitivity, and strict compliance with the regulatory standards of health authorities worldwide – a commitment that solidifies Acolad's role as a trusted partner in global healthcare communication.